Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with huntington disease(476 views) Esmaeilzadeh M, Kullingsjo J, Ullman H, Varrone A, Tedroff J
Keywords: Acr16, Brain Metabolism, Fdg Pet Imaging, Huntington Disease, Pridopidine, Fluorodeoxyglucose F 18, Adult, Article, Brain Region, Clinical Article, Clinical Assessment, Drug Dose Increase, Drug Safety, Drug Tolerability, Female, Glucose Brain Level, Glucose Metabolism, Human, Huntington Chorea, Metabolic Rate, Open Study, Positron Emission Tomography, Precuneus, Priority Journal, Rating Scale, Thalamus Dorsomedial Nucleus, Energy Metabolism, Middle Aged, Piperidines, Positron-Emission Tomography, Treatment Outcome,
Affiliations: *** IBB - CNR ***
Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital, Stockholm, SE-17176, Sweden
NeuroSearch Sweden AB, Stockholm, Sweden
References: Not available.
Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with huntington disease